Laboratory Corporation of America Holdings (LabCorp) Enhances HCV Testing Services with the Launch of IL-28B Test

Published: Aug 24, 2010

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the nationwide availability of a genetic test to detect the presence of a single polymorphism within the IL-28B gene that has been reported to help predict a person’s response to certain hepatitis C virus (HCV) therapies.

Back to news